Wegovy vs Mounjaro: which is better for you?

Before we start

This article is general information, not medical advice. Wegovy and Mounjaro are prescription-only medicines. Whether either suits you depends on a proper medical assessment, and the figures below are meant as context for a conversation with a doctor, not as a reason to self-prescribe or buy from an online seller.

I say that because I have had patients arrive already injecting something they bought off social media, at a dose nobody supervised. Please do not be that patient.

With that out of the way: in the only large head-to-head trial run so far, Mounjaro produced more weight loss than Wegovy. That does not automatically make it right for you. Better on average is not the same as better for your body.

What is Wegovy?

Wegovy is the brand name for semaglutide used in weight management. It belongs to a group called GLP-1 receptor agonists, which mimic a natural gut hormone that tells your brain you are full. The result is less appetite, fewer cravings, and slower stomach emptying. You feel satisfied on less food and think about eating less across the day.

It is a weekly injection. The dose goes up slowly over several weeks, commonly towards 2.4mg, so the body can adjust and side effects stay manageable. It is approved specifically for weight management, and it works alongside changes to how you eat and move, not instead of them.

What is Mounjaro?

Mounjaro is the brand name for tirzepatide. The difference is that it acts on two hormone pathways rather than one, GLP-1 and a second gut hormone called GIP. That is why you will see it described as a dual agonist, and it appears to give a stronger effect on appetite and blood sugar for many people.

Like Wegovy it is a weekly injection with a dose titrated slowly, usually starting at 2.5mg and climbing towards 5, 10 or 15mg.

One naming point confuses almost everyone. Mounjaro was first approved for type 2 diabetes, and in some countries the same tirzepatide is sold under a different brand name specifically for weight loss. The medicine inside the pen is the same.

The head-to-head numbers

Most articles compare these two by lining up results from separate trials. That is misleading, because the studies enrolled different people under different conditions. The comparison worth reading is the one direct trial, SURMOUNT-5.

The direct evidence does favour Mounjaro on weight loss. Keep in mind these are averages from a trial. Individual results vary a great deal with your starting point, your habits, and how consistently you stick to the plan.

Side effects and safety

Because they work in similar ways, the side effect profile is similar, and mostly digestive. Nausea, vomiting, diarrhoea and constipation are the common ones. They tend to be worst in the early weeks while the dose is climbing, then settle for most people.

There are also serious safety points that any responsible clinic will raise with you:

• Both carry a boxed warning about a risk of certain thyroid tumours seen in animal studies.
• Neither is suitable if you or a family member has had medullary thyroid cancer, or the condition MEN2.
• There is caution around pancreatitis and gallbladder problems.

This is precisely why these medicines need a doctor who reviews your history, monitors you and adjusts the dose. Not a website that ships a pen.

Can you switch between them?

People ask this often, usually hoping for more result, or wanting to move the other way because of side effects, cost or supply.

Switching is possible under medical supervision. But it is not a matter of swapping one pen for another at the same dose. A doctor will normally restart you low on the new medicine and titrate up again, so the side effects stay manageable. Doing it yourself risks a rough few weeks, or worse.

Availability and cost in Malaysia

Availability here changes over time, and global supply has been inconsistent. Check with a clinic or pharmacy rather than relying on a blog post, including this one.

As a rough guide, monthly costs in Malaysia have tended to sit somewhere between RM1,000 and RM1,600, varying with brand, dose and where you get it. A valid prescription is mandatory.

Significant weight change also affects how the face and body look, which is why some patients plan supportive treatments once their weight is stable. Our body slimming page covers what is realistic on that side of things.

Which one is better for you?

On pure weight loss, the direct trial favours Mounjaro. But the better question is which is right for you, and that depends on more than one number: your medical history, how your body handles the side effects, whether blood sugar or diabetes is part of the picture, your budget, and what is actually in stock.

Some patients do very well on Wegovy and prefer it. Others get more from Mounjaro. That decision belongs with a doctor who can see your whole health picture and follow you safely.

In summary

Both are evidence-backed tools for weight management, and the direct trial gives Mounjaro the edge on average weight loss. Even so, the right choice is personal. These are medical treatments, not shortcuts, and they work best under proper guidance alongside changes you can actually keep up.

The sensible next step is not to pick a winner from a blog post. Message us and one of our doctors will go through your options and whether either is suitable for you.